Bicara Therapeutics Inc.

Q4 2024 13F Holders

Symbol
BCAX
CUSIP
055477103
Type
Equity
Class
COM
Num filings
86
Total reported value, excl. options
$825 M
Manager Report Date Value ($000) Shares Option Type